- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02676934
End Tidal Control of Sevoflurane (EtCntrl)
February 3, 2016 updated by: AlRefaey Kandeel, Mansoura University
the study compares the use of end tidal (Et) control of sevoflurane during anesthesia for living donor hepatectomy versus fresh gas (FGF) control.
Et control is hypothesized to be as effective as FGF control with less cost and more operator satisfaction.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Dakahleya
-
Mansoura, Dakahleya, Egypt, 62215
- Mansoura University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 43 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- all donors scheduled for living donor hepatectomy in Mansoura liver transplant program
Exclusion Criteria:
- refusal
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Et group
applying end tidal concentration as a control target for delivery of sevoflurane
|
THE USE OF AUTOMATED CONTROL OF END TIDAL SEVOFLURANE CONCENTRATION TO MAINTAIN ANESTHESIA DURING DONOR HEPATECTOMY
|
No Intervention: FGF group
using Fresh gas control for sevoflurane delivery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
cost of sevoflurane during anesthesia
Time Frame: Intra-operative period
|
Intra-operative period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2015
Primary Completion (Actual)
January 1, 2016
Study Completion (Actual)
January 1, 2016
Study Registration Dates
First Submitted
February 1, 2016
First Submitted That Met QC Criteria
February 3, 2016
First Posted (Estimate)
February 9, 2016
Study Record Updates
Last Update Posted (Estimate)
February 9, 2016
Last Update Submitted That Met QC Criteria
February 3, 2016
Last Verified
February 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R-ETCNTRL
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anesthesia of Living Donor Hepatectomy
-
AlRefaey KandeelCompletedLiving Donor HepatectomyEgypt
-
National Taiwan University HospitalUnknown
-
Central Hospital, Nancy, FranceInstitut National de la Santé Et de la Recherche Médicale, France; University...CompletedLiving Donor of KidneyFrance
-
Prof. Dr. Petra ReinkeCompletedImmunosuppressive Treatment of Living-donor Renal TransplantationGermany
-
Mansoura UniversityCompleted
-
Seoul National University HospitalCompletedCVP and SVV During Living Donor Hepatectomy | Surgical Field Grade (Condition of Surgical Field; Bleeding, Tension of the IVC)Korea, Republic of
-
Beth Israel Deaconess Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Columbia UniversityWithdrawnLiving Renal DonorUnited States
-
National Institute of Allergy and Infectious Diseases...Rho Federal Systems Division, Inc.; Clinical Trials in Organ Transplantation...CompletedLiver Transplant Recipient | Living Donor (of the Respective Liver Transplant Recipient)United States